Nardostachys jatamansi, a medicinally important herb of Nepalese origin, has been used for centuries in the Ayurvedic and Unani systems of medicine. In combination with Marsilea minuta it is being used as an antistress and anticonvulsant drug and also finds use in the treatment of epilepsy. Recently, it has been reported that N. jatamansi, which plays an important role in protecting from cerebral ischemia and liver damage, is also used for the treatment of osteoporosis and hypercalcemia. The other member of the genus Nardostachys, N. chinensis, possesses antifungal and antimalarial properties. It is also used in the treatment of skin dysfunction. A short summary of the chemical constituents of the two species along with their physical and biological properties is reported.
DukeJA, AyensuES. (1985) Medicinal Plants of China. Reference Publications.
6.
Stuart RevGA. (1976) Chinese Materia Medica.Taipei.
7.
ChatterjeeA, MukherjeeGD, MajhiSN, BhattacharyaP. (1984) CCRAS, New Delhi, Indian Patent No. 14170 dt.14.7.1976.
8.
SunHD, DingJK, LinZW, CheFR. (1980) Study on the chemical constituents of the essential oils of Nardostachys grandiflora DC. and N. chinensis Batalin and their uses on the perfume. Yunnan Zhiwu Yanjiu, 2, 213–223.
9.
PesnelleP, OurissonG. (1963) Aristolene isolation in nard essence. Bulletin de la Societe Chimique de France, 912–913.
10.
MaheshwariML, SaxenaDB. (1980) 9-Aristolen-1α-ol and 1(10)-aristolen-2-one from Nardostachys jatamansi DC. Indian Perfumer, 24, 171–174.
11.
SastrySD, MaheshwariML, ChakravartiKK, BhattacharyyaSC. (1967) Terpenoids. CXV. Chemical constituents of Nardostachys jatamansi.Perfumery and Essential oil Record, 58, 154–158.
12.
RueckerG, KretzschmarU. (1971) 9-Aristolen-1-α-ol and 1,2,9,10-tetradehydroaristolane, new aristolane-type sesquiterpenes. Justus Liebigs Annalen der Chemie, 748, 214–217.
13.
ShideL, OlbrichA, MayerR, RueckerG. (1987) Gansongone, a new aristolane ketone from Nardostachys chinensis and structure revision of an aristolenol. Planta Medica, 53, 556–558.
14.
HanY, XiaoD, XiangY, YeL, ChengC. (2000) Study on the volatile oil of Nardostachys chinensis.Zhong yao cai, 23, 34–35.
15.
MahalwalVS, AliM. (2002) Volatile constituents of the rhizomes of Nardostachys jatamansi DC. Journal of Essential Oil-Bearing Plants, 5, 83–89.
16.
BuechiG, GreuterF, TokoroyamaT. (1962) Terpenes. XVII. Structure of calarene and stereochemistry of aristolone. Tetrahedron Letters, 827–833.
17.
CostaR, De FinaMR, ValentinoMR, DugoP, MondelloL. (2007) Reliable identification of terpenoids and related compounds by using linear retention indices interactively with mass spectrometry search. Natural Product Communications, 2, 413–418.
18.
RueckerG. (1968) 1(10)-Aristolen-2-one and 1,8,9,10-tetradehydroaristolan-2-one, new sesquiterpene ketones of the aristolan type. Justus Liebigs Annalen der Chemie, 717, 221–224.
19.
RueckerG. (1969) Components of commercial Chinese spikenard oil (Nardostachys jatamansi). Planta Medica, 17, 32–34.
20.
RueckerG, ShideL, OlbrichA. (1990) Peroxides as plant constituents. VII. Formation of the sesquiterpene peroxide nardosinone from an aristolane precursor. Archiv der Pharmazie, 323, 171–175.
21.
ItokawaH, MasuyamaK, MoritaH, TakeyaK. (1993) Cytotoxic sesquiterpenes from Nardostachys chinensis.Chemical and Pharmaceutical Bulletin, 41, 1183–1184.
22.
RueckerG. (1971) 9-hydroxy-delta-1(10)-aristolen-2-one (debilon) from Nardostachys chiniensis.Planta Medica, 19, 16–18.
23.
ZhangY, LuY, ZhangL, ZhengQ-T, XuL-Z, YangS-L. (2005) Terpenoids from the Roots and Rhizomes of Nardostachys chinensis.Journal of Natural Products, 68, 1131–1133.
SchulteKE, RueckerG, GlauchG. (1967) Some components of the subterranean parts of Nardostachys chinensis.Planta Medica, 15, 274–281.
26.
HoersterH, RueckerG, TautgesJ. (1977) Valeranone content in the roots of Nardostachys jatamansi and Valeriana officinalis.Phytochemistry, 16, 1070–1071.
27.
ShanbhagSN, MestaCK, MaheshwariML, PaknikarSK, BhattacharyyaSC. (1964) Terpenoids. LII. Jatamansin, a new terpenic coumarin from Nardostachys jatamansi.Tetrahedron, 20, 2605–2615.
28.
NavesYR. (1963) Essential oils. CLXXXVII. Presence of maaliol and valeranone in oil of Nardostachys jatamansi.Helvetica Chimica Acta, 46, 2139–2141.
29.
SastrySD, MaheshwariML, ChakravartiKK, BhattacharyyaSC. (1967) Terpenoids. CVI. The structure of calarenol. Tetrahedron, 23, 1997–2000.
30.
BagchiA, OshimaY, HikinoH. (1988) The validity of oriental medicines. Part 127. Sesquiterpenoids. Part 62. Kanshone C, a sesquiterpenoid of Nardostachys chinensis roots. Phytochemistry, 27, 2877–2879.
31.
BagchiA, OshimaY, HikinoH. (1991) Jatamols A and B: sesquiterpenoids of Nardostachys jatamansi roots. Planta Medica, 57, 282–283.
32.
ShanbhagSN, MestaCK, MaheshwariML, BhattacharyyaSC. (1965) Terpenoids. LXXV. Constituents of Nardostachys jatamansi and synthesis of (±)-dihydrosamidin and visnadin from jatamansin. Tetrahedron, 21, 3591–3597.
TakayaY, TakeujiY, AkasakaM, NakagawasaiO, TadanoT, KisaraK, KimHS, WatayaY, NiwaM, OshimaY. (2000) Novel Guaiane Endoperoxides, Nardoguaianone A-D, from Nardostachys chinensis Roots and their Antinociceptive and Antimalarial Activities. Tetrahedron, 56, 7673–7678.
37.
KawashimaA, KishimotoM, MorimotoS, AkyamaT, MaejimaA, KawadaI. (1996) Extraction of novel compound BR-606 from Nardostachys jatamansi roots as bone sorption inhibitor for treatment of osteoporosis and hypercalcemia. Japan Kokai Tokkyo Koho, 5 pp.
RueckerG, TautgesJ. (1974) Structure of jatamansic acid. Archiv der Pharmazie, 307, 791–795.
40.
RueckerG, TautgesJ, SieckA, WenzlH, GrafE. (1978) Studies on isolation and pharmacodynamic activity of the sesquiterpene valeranone from Nardostachys jatamansi DC. Arzneimittel-Forschung, 28, 7–13.
RueckerG. (1975) Structure of nardosinone. VII. Configuration of nardosinone. Justus Liebigs Annalen der Chemie, 311–315.
43.
GovindachariTR, RajaduraiS, PaiBR. (1958) Structure of jatamanson. I. Chemische Berichte, 91, 908–910.
44.
AroraRB, SharmaPL, KapilaK. (1958) Antiarrhythmic and anticonvulsant activity of jatamansone. Indian Journal of Medical Research, 46, 782–791.
45.
ChaudhryGR, SharmaVN, SiddiquiS. (1951) Chemical constituents of Nardostachys jatamanshi. I. Isolation of a crystalline acid and an essential oil. Journal of Scientific and Industrial Research, 10B, 48.
46.
ChaudhryGR, DharMM, AnandN, DharML (1958) Structure of jatamanshic acid. Journal of Scientific and Industrial Research (India), 17B, 159–162.
ChatterjeeA, BasakB, SahaM, DuttaU, MukhopadhyayC, BanerjiJ, KondaY, HarigayaY. (2000) Structure and Stereochemistry of Nardostachysin, a New Terpenoid Ester Constituent of the Rhizomes of Nardostachys jatamansi.Journal of Natural Products, 63, 1531–1533.
49.
BagchiA, OshimaY, HikinoH. (1988) The validity of the oriental medicines. Part 130. Sesquiterpenoids. Part 63. Kanshones D and E, sesquiterpenoids of Nardostachys chinensis roots. Phytochemistry, 27, 3667–3669.
50.
RueckerG. (1970) Structure of nardosinone. IV. Constitution of isonardosinone. Justus Liebigs Annalen der Chemie, 733, 152–158.
51.
ShideL, MayerR, RueckerG. (1987) Nardonoxide, a new nardosinane-type sesquiterpene ether from Nardostachys chinensis.Planta Medica, 53, 332–334.
52.
BagchiA, OshimaY, HikinoH. (1988) Sesquiterpenoids. Part 61. Kanshones A and B, sesquiterpenoids of Nardostachys chinensis.Phytochemistry, 27, 1199–1220.
53.
SchulteKE, GlauchG, RuckerG. (1965) Nardosinone, a new constituent of Nardostachys chinensis Batalin. Tetrahedron Letters, 35, 3083–3084.
54.
ToriM, FurutaH, AsakawaY. (1991) Total synthesis of kanshone A, a sesquiterpene isolated from Nardostachys chinensis (Valerianaceae). Journal of the Chemical Society, Perkin Transaction I: Organic and Bio-organic Chemistry, 8, 1919–1922.
55.
HikinoH, HikinoY, KoakutsuS, TakemotoT. (1972) Sesquiterpenoids. XLV. Structure and absolute configuration of narchinol A. Phytochemistry, 11, 2097–2099.
56.
SaundersWD, PinderAR. (1977) Further studies relating to the structure of nardostachone. Tetrahedron Letters, 20, 1687–1690.
57.
RueckerG, TautgesJ, MaheswariML, SaxenaDB. (1976) Norseychelanone, α - and β -patchoulenes and patchouli alcohol from Nardostachys jatamansi.Phytochemistry, 15, 224.
58.
RuckerG, KretzschmarU. (1972) Patchouli alcohol and beta patchoulene from Nardostachys chinensis.Planta Medica, 21, 1–4.
59.
HuangHe, ForsythCJ. (1995) Anti Selective Spirocarbomercuration: Synthesis and Stereochemistry of the Spirobicyclic Sesquiterpenes Spirojatamol and Erythrodiene. Journal of Organic Chemistry, 60, 2773–2779.
60.
BagchiA, OshimaY, HikinoH. (1990) Sesquiterpenoids. Part 64. Spirojatomol, a new skeletal sesquiterpenoid of Nardostachys jatamansi roots. Tetrahedron, 46, 1523–1530.
61.
MaheshwariML, SaxenaDB. (1974) Seychellene and seychelane from Nardostachys jatamansi.Indian Journal of Chemistry, 12, 1221–1222.
62.
ChatterjeeA, BasakB, DuttaU, BanerjiJ, NeumanA, PrangéT. (2005) Studies on the chemical constituents of Nardostachys jatamansi DC (Valerianaceae). Indian Journal of Chemistry, 44B, 430–433.
63.
BagchiA, OshimaY, HikinoH. (1988) Validity of the Oriental medicines. Part 123. Nardostachin, an iridoid of Nardostachys chinensis.Planta Medica, 54, 87–88.
64.
BagchiA, OshimaY, HikinoH. (1991) Neolignans and lignans of Nardostachys jatamansi roots. Planta Medica, 57, 96–97.
65.
HiroseY, YonemitsuK, SonodaT. (1978) Chemical studies on the components of Nardostachys jatamansi de Candolle I. Shoyakugaku Zasshi, 32, 121–122.
66.
SinghV, AliM. (2003) New phytoconstituents from Nardostachys jatamansi rhizomes. Journal of Saudi Chemical Society, 7, 119–128.
67.
ModySB, ModyPD, VasavadaSA. (1997) An improved process for extraction of the Ayurvedic plant jatamansi (Nardostachys jatamansi), (J.B. Chemicals & Pharmaceuticals Ltd., India), 13 pp.
68.
BenvenisteH. (1991) The excitotoxin hypothesis in relation to cerebral ischemia. Cerebrovascular and Brain Metabolism Reviews, 3, 213–245.
69.
ChoiDW. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron, 1, 623–634.
HamiedKA, BakshiVM, AgharaLP. (1962) Pharmacological investigation of Nardostachys jatamansi root. Journal of Scientific and Industrial Research, Section B: Physical Sciences, 21c, 100–103.
72.
PrabhuV, KaranthKS, RaoA. (1994) Effects of Nardostachys jatamansi on biogenic amines and inhibitory amino acids in the rat brain. Planta Medica, 60, 114–117.
73.
HoughtonPJ. (1999) The scientific basis for the reputed activity of Valerian. Journal of Pharmacy and Pharmacology, 51, 505–512.
74.
FridovichI. (1978) The biology of oxygen radicals. Science, 201, 875–880.
75.
AdlardBP, deSouzaSW, MoonS. (1973) The effect of age, growth retardation and asphyxia on ascorbic acid concentrations in developing brain. Journal of Neurochemistry, 21, 877–881.
76.
FolbergrovaJ, RehncronaS, SiesjoeBK. (1979) Oxidized and reduced glutathione in the rat brain under normoxic and hypoxic conditions. Journal of Neurochemistry, 32, 1621–1627.
77.
SalimS, AhmadM, ZafarKS, AhmadAS, IslamF. (2003) Protective effect of Nardostachys jatamansi in rat cerebral ischemia. Pharmacology, Biochemistry and Behavior, 74, 481–486.
78.
AgrawalSS, SharmaRC, AroraRB. (1973) Antioestrogenic activity of jatamansone semicarbazone. Indian Journal of Experimental Biology, 11, 583.
